Table 4.
Multiple regression analyses of the association between dietary vitamin D and metabolic syndrome and its parameters in class II/III obesity.
| Variables | Model 1 Vitamin D Dietary p50 (<70.4 IU/Day) |
Model 2 Vitamin D Dietary p50 (<70.4 IU/Day) |
Model 3 Vitamin D Dietary p50 (<70.4 IU/Day) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| PR | CI 95% | p * | PR | CI 95% | p * | PR | CI 95% | p * | |
| Glycaemia | |||||||||
| <100 mg/dL | 1 | 1 | 1 | ||||||
| ≥100 mg/dL or medicament |
0.976 | 0.693–1.375 | 0.891 | 0.906 | 0.504–1.630 | 0.743 | 0.868 | 0.474–1.588 | 0.645 |
| HDL–cholesterol lower | |||||||||
| ≥40 mg/dL or ≥50 mg/L | 1 | 1 | 1 | ||||||
| <40 mg/dL or <50 mg/L or medicament |
0.972 | 0.742–1.274 | 0.840 | 0.912 | 0.644–1.291 | 0.603 | 0.930 | 0.654–1.325 | 0.690 |
| Triacylglycerol | |||||||||
| <150 mg/dL | 1 | 1 | 1 | ||||||
| ≥150 mg/dL or medicament |
1.032 | 0.735–1.451 | 0.854 | 1.219 | 0.736–2.019 | 0.440 | 1.2240 | 0.729–2.057 | 0.444 |
| Abdominal circumference | |||||||||
| <129.9 cm or 124.6 cm | 1 | 1 | – | – | – | ||||
| ≥129.9 or ≥124.6 m | 0.969 | 0.863–1.088 | 0.596 | 1.020 | 0.879–1.184 | 0.792 | – | – | – |
| Blood pressure | |||||||||
| <130/85 mmHg | 1 | 1 | 1 | ||||||
| ≥130/85 mmHg or medicament | 1.043 | 0.821–1.324 | 0.729 | 0.830 | 0.566–1.218 | 0.342 | 0.825 | 0.558–1.222 | 0.338 |
| Metabolic syndrome | |||||||||
| No | 1 | 1 | 1 | ||||||
| yes | 0.968 | 0.784–1.194 | 0.760 | 0.837 | 0.589–1.1882 | 0.319 | 0.797 | 0.564–1.125 | 0.196 |
* Poisson regression. PR (prevalence ratio). CI (confidence interval). Model 1: sex, age, schooling years, social class. Model 2: model 1 + smoking e binge drinking. Model 3: model 1 + model 2 + BMI.